Drugs Made In America Acquisition Corp. Ordinary Shares
DMAA | NASDAQ
$10.85
$0 (0.00%)
At close: Sep 22, 2026, 4:00 PM ET
$10.85
$0 (0.00%)
After-hours:
Sep 22, 2026, 4:00 PM ET
Market Data
Market Cap $263.4M
Enterprise Value $264.33M
Beta 0.00
Average Volume 28.36K
Shares Outstanding (Diluted) 20.1M
Shares Change YoY -40.04%
Institutional Ownership 99.43%
Exchange NASDAQ
ISIN KYG2847J1040
Price Performance
Price Change 1M 0.8%
Price Change 3M 2.0%
Price Change 6M 3.3%
Price Change YTD 4.5%
Price Change 1Y 5.3%
Price Change 3Y 8.8%
Price Change 5Y 8.8%
1M CAGR (ann.) 1.3%
1Y CAGR (ann.) 5.5%
5Y CAGR (ann.) N/A
All-Time CAGR 5.6%
Valuation
PE Ratio 54.25
Forward PE N/A
PEG Ratio -0.55
Forward PEG -0.55
PS Ratio N/A
Forward PS N/A
PB Ratio 1.91
P/FCF Ratio -815.16
P/Adj. FCF Ratio -815.16
P/OCF Ratio -542.50
EV/Sales N/A
EV/EBIT -100.38
EV/EBITDA -100.38
EV/FCF -818.04
Earnings Yield 1.8%
FCF Yield -0.1%
Adj. FCF Yield -0.1%
Financial Health
Net Debt $929.72K
Total Debt $950K
Cash & Short-Term Investments $20.28K
Total Assets $146.9M
Current Ratio 0.02
Quick Ratio 0.02
Debt / Equity Ratio 0.01
Debt / EBITDA -0.36
Debt / FCF -2.94
OCF / Debt -0.34
Interest Coverage 0.00
Altman Z-Score 17.14
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets 4.2%
Return on Equity 2.9%
Return on Invested Capital -1.8%
Return on Capital Employed -1.8%
Return on Tangible Assets 4.2%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number $5.56
Graham Upside -48.8%
Lynch Fair Value N/A
Lynch Upside N/A
Price Target N/A
Price Target Upside N/A
Cash Flow
Operating Cash Flow $-323.13K
Free Cash Flow $-323.13K
Adj. Free Cash Flow $-323.13K
FCF Per Share -$0.02
OCF Per Share -$0.02
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-2.63M
EBITDA $-2.63M
Net Income $6.09M
EPS (Diluted) $0.20
Revenue / Employee N/A
Profit / Employee $3.05M
Employees 2
Add to Watchlist
Select watchlists to add or remove DMAA